Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BIOSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.21
N/A
NA
vs NA
Q2.21
N/A
NA
vs NA
Q3.21
N/A
NA
vs NA
Q4.21
N/A
NA
vs NA
Q1.22
N/A
NA
vs NA
Q2.22
N/A
NA
vs NA
Q3.22
N/A
NA
vs NA
Q4.22
N/A
0.16
vs NA
Q1.23
N/A
0.21
vs NA
Q2.23
N/A
0.06
vs NA
Sales Growth
YoY
Current
Estimates
Q1.21
NA
NA vs NA
Q2.21
NA
NA vs NA
Q3.21
NA
NA vs NA
Q4.21
NA
NA vs NA
Q1.22
NA
NA vs NA
Q2.22
NA
NA vs NA
Q3.22
NA
NA vs NA
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Return on Equity
QoQ
Q3.21
-5%
-0.05
vs -60.45
Q4.21
0%
-0.00
vs -0.05
Q1.22
0%
-0.00
vs -0.00
Q2.22
+0%
0
vs -0.00
Q3.22
+1%
0.01
vs 0
Q4.22
+2%
0.02
vs 0.01
Q1.23
+2%
0.02
vs 0.02
Q2.23
+1%
0.01
vs 0.02
Institutionnal Ownership
QoQ
Q1.22
45
45
vs NA
NA
Q2.22
55
55
vs 45
22%
Q3.22
51
51
vs 55
-7%
Q4.22
47
47
vs 51
-8%
Q1.23
47
47
vs 47
NA
Q2.23
48
48
vs 47
2%
Q3.23
49
49
vs 48
2%
BioPlus Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
NASDAQ
-0.00Â ( -17.65%)
Pre-market NaN$
0.00 (0.00%)
Relative Strenght
1
Volume Buzz
100%
Earning Acce
No
Dist 52w H.
100%Forecast
No Data Available
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
BIOSW
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How BIOSW compares to sector?